<DOC>
	<DOCNO>NCT01967355</DOCNO>
	<brief_summary>Preeclampsia disease occur 6-8 % pregnancy main cause maternal fetal morbidity mortality . The cause preeclampsia still clear therapy preterm caesarean section . In severe preeclampsia accumulation triglyceride-rich lipoprotein occurs . Therefore , lipid apheresis perform lipid-removing therapy treatment preeclampsia order prolong pregnancy provide fetus time maturation . In individual treatment patient early preeclampsia ( &lt; = 32 week gestation ) offer H.E.L.P.-apheresis postpone caesarean section therefore prolong pregnancy .</brief_summary>
	<brief_title>Prolongation Pregnancy Preeclampsia Therapeutic Lipid Apheresis</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<criteria>pregnant woman early preeclampsia ( &lt; 32 week pregnancy ) arterial hypertension pregnancy proteinuria ( = &gt; 1 + dipstick 0 &gt; 300 mg/24h ) and/or intrauterine growth retardation ( IUGR ) inform consent every acute indication immediate delivery inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>preeclampsia</keyword>
	<keyword>lipid apheresis</keyword>
	<keyword>apheresis</keyword>
</DOC>